Spec stocks will get hammered first, this one has liquidity issues so when the sell is on it on and vice versa. I am down, but happy to hold as the fully funded drill results roll through.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential